Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Northwest Biotherapeutics Inc (NASDAQ:NWBO)

During the Trading Day
1.97 +0.09 / +4.79%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
1.97 0.00 / 0.00%
 
Volume: 6.2K

Today’s Trading

Previous close1.88
Today’s open1.97
Day’s range1.86 - 1.99
Volume217,275
Average volume (3 months)481,950
Market cap$180.2M
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-14.50%
Earnings growth (this year)--
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+79.73%
P/E ratioNM
Price/Sales218.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NBRVNabriva Therapeutics...0.000.00%
IMDZImmune Design Corp+0.27+3.04%
MYOKMyoKardia Inc+0.01+0.15%
SRNESorrento Therapeutic...+0.63+12.88%
Data as of 4:00pm ET, 02/12/2016

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$1.5M
Annual profit (last year)-$135.6M
Net profit margin-9,328.34%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO, CFO &
CAO
Linda F. Powers
Chief Scientific Officer, Secretary &
Director
Alton L. Boynton
Corporate headquarters
Bethesda, Maryland

Forecasts

Partner Offers